Biofrontera Inc. Names Gerard DiGirolamo as National Sales
WOBURN, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...
Source: globenewswire.com
Page 4 - Nasdaq Bfri News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq Bfri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Bfri Today - Breaking & Trending Today
Biofrontera Inc.'s Leslie Hopkins Named PM360 Trailblazer
WOBURN, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...
Source: globenewswire.com
Biofrontera Inc. Announces Exercise of Existing Warrants
WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...
Source: globenewswire.com
Biofrontera (NASDAQ:BFRI) Rating Increased to Hold at Zacks Investment Research
Biofrontera (NASDAQ:BFRI – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Friday, Zacks.com reports. According to Zacks, “Biofrontera Inc. is a biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on the fields […]
Source: etfdailynews.com
Zacks Investment Research Lowers Biofrontera (NASDAQ:BFRI) to Sell
Biofrontera (NASDAQ:BFRI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report released on Friday, Zacks.com reports. According to Zacks, “Biofrontera Inc. is a biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on the fields of […]
Source: etfdailynews.com